Millennium Management
AVBP icon

Millennium Management’s ArriVent BioPharma AVBP Stock Holding History

Millennium Management’s Portfolio AVBP Stock Details AVBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.83M Buy
425,923
+143,971
+51% +$3.25M ﹤0.01% 2185
2025
Q4 		$5.67M Sell
281,952
-4,152
-1% -$86.4K ﹤0.01% 2874
2025
Q3 		$5.28M Buy
286,104
+109,935
+62% +$2.16M ﹤0.01% 3096
2025
Q2 		$3.84M Buy
176,169
+18,111
+11% +$376K ﹤0.01% 3257
2025
Q1 		$2.92M Buy
158,058
+105,513
+201% +$2.58M ﹤0.01% 3425
2024
Q4 		$1.4M Sell
52,545
-164,085
-76% -$4.71M ﹤0.01% 3917
2024
Q3 		$5.09M Buy
216,630
+204,527
+1,690% +$4.64M ﹤0.01% 2824
2024
Q2 		$225K Sell
12,103
-199,586
-94% -$3.56M ﹤0.01% 5077
2024
Q1 		$3.78M Buy
+211,689
New +$4.27M ﹤0.01% 3153

Other funds holding AVBP

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management's AVBP Position: Q1 2026 in Review

Millennium Management increased its ArriVent BioPharma (AVBP) stake by 51% in Q1 2026, buying an estimated $3.25M and bringing the position to 425,923 shares worth $9.83M. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

Millennium Management first reported a position in AVBP in Q1 2024 and has held it in 9 quarters since. 139 funds tracked by Wall St. Rank hold AVBP as of Q1 2026.

  • Millennium Management held 425,923 shares of ArriVent BioPharma worth $9.83M as of Q1 2026.
  • Millennium Management bought 143,971 ArriVent BioPharma shares in Q1 2026, an estimated $3.25M.
  • ArriVent BioPharma made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2185 holding.
  • Millennium Management first reported a position in ArriVent BioPharma in Q1 2024 and has held it in 9 quarters since.
  • 139 funds tracked by Wall St. Rank held ArriVent BioPharma as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.